Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1980 3
1981 1
1983 1
1984 3
1985 4
1986 2
1987 5
1988 3
1989 3
1990 4
1991 11
1992 12
1993 12
1994 13
1995 11
1996 6
1997 7
1998 4
1999 6
2000 2
2001 1
2002 1
2003 6
2004 6
2005 6
2006 5
2007 9
2008 5
2009 17
2010 16
2011 9
2012 20
2013 15
2014 14
2015 8
2016 11
2017 10
2018 5
2019 8
2020 14
2021 11
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

300 results
Results by year
Filters applied: . Clear all
Page 1
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors.
Vasan N, Razavi P, Johnson JL, Shao H, Shah H, Antoine A, Ladewig E, Gorelick A, Lin TY, Toska E, Xu G, Kazmi A, Chang MT, Taylor BS, Dickler MN, Jhaveri K, Chandarlapaty S, Rabadan R, Reznik E, Smith ML, Sebra R, Schimmoller F, Wilson TR, Friedman LS, Cantley LC, Scaltriti M, Baselga J. Vasan N, et al. Among authors: friedman ls. Science. 2019 Nov 8;366(6466):714-723. doi: 10.1126/science.aaw9032. Science. 2019. PMID: 31699932 Free PMC article.
Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its Mobility.
Guan J, Zhou W, Hafner M, Blake RA, Chalouni C, Chen IP, De Bruyn T, Giltnane JM, Hartman SJ, Heidersbach A, Houtman R, Ingalla E, Kategaya L, Kleinheinz T, Li J, Martin SE, Modrusan Z, Nannini M, Oeh J, Ubhayakar S, Wang X, Wertz IE, Young A, Yu M, Sampath D, Hager JH, Friedman LS, Daemen A, Metcalfe C. Guan J, et al. Among authors: friedman ls. Cell. 2019 Aug 8;178(4):949-963.e18. doi: 10.1016/j.cell.2019.06.026. Epub 2019 Jul 25. Cell. 2019. PMID: 31353221 Free article.
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Hatzivassiliou G, Song K, Yen I, Brandhuber BJ, Anderson DJ, Alvarado R, Ludlam MJ, Stokoe D, Gloor SL, Vigers G, Morales T, Aliagas I, Liu B, Sideris S, Hoeflich KP, Jaiswal BS, Seshagiri S, Koeppen H, Belvin M, Friedman LS, Malek S. Hatzivassiliou G, et al. Among authors: friedman ls. Nature. 2010 Mar 18;464(7287):431-5. doi: 10.1038/nature08833. Epub 2010 Feb 3. Nature. 2010. PMID: 20130576
Systemic causes of cholestasis.
Delemos AS, Friedman LS. Delemos AS, et al. Among authors: friedman ls. Clin Liver Dis. 2013 May;17(2):301-17. doi: 10.1016/j.cld.2012.11.001. Epub 2013 Jan 26. Clin Liver Dis. 2013. PMID: 23540504 Free PMC article. Review.
Treatment of Dyslipidemia in Common Liver Diseases.
Speliotes EK, Balakrishnan M, Friedman LS, Corey KE. Speliotes EK, et al. Among authors: friedman ls. Clin Gastroenterol Hepatol. 2018 Aug;16(8):1189-1196. doi: 10.1016/j.cgh.2018.04.023. Epub 2018 Apr 21. Clin Gastroenterol Hepatol. 2018. PMID: 29684459 Free PMC article. Review. No abstract available.
Teaching in the office.
Friedman LS. Friedman LS. Dig Dis Sci. 2015 Apr;60(4):832-4. doi: 10.1007/s10620-015-3623-y. Dig Dis Sci. 2015. PMID: 25764499 No abstract available.
Pharmacotherapy for Friedreich ataxia.
Tsou AY, Friedman LS, Wilson RB, Lynch DR. Tsou AY, et al. Among authors: friedman ls. CNS Drugs. 2009;23(3):213-23. doi: 10.2165/00023210-200923030-00003. CNS Drugs. 2009. PMID: 19320530 Review.
Lower gastrointestinal bleeding.
Bounds BC, Friedman LS. Bounds BC, et al. Among authors: friedman ls. Gastroenterol Clin North Am. 2003 Dec;32(4):1107-25. doi: 10.1016/s0889-8553(03)00086-4. Gastroenterol Clin North Am. 2003. PMID: 14696299 Review.
Irritable bowel syndrome.
Lynn RB, Friedman LS. Lynn RB, et al. Among authors: friedman ls. N Engl J Med. 1993 Dec 23;329(26):1940-5. doi: 10.1056/NEJM199312233292608. N Engl J Med. 1993. PMID: 8305064 Review. No abstract available.
300 results